Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,599 | -8,939 | -7,323 | -5,299 | -2,805 |
| Depreciation Amortization | 28 | 112 | 86 | 59 | 30 |
| Accounts receivable | -6 | 17 | 30 | N/A | 34 |
| Other Working Capital | 110 | 358 | 326 | 58 | -30 |
| Other Operating Activity | 96 | 1,076 | 906 | 727 | 406 |
| Operating Cash Flow | $-1,372 | $-7,375 | $-5,976 | $-4,455 | $-2,365 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 3,833 | 3,833 | 3,833 | 3,776 |
| PPE Investments | N/A | -42 | -43 | -34 | -32 |
| Investing Cash Flow | $N/A | $3,791 | $3,790 | $3,799 | $3,744 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -65 | -31 | 0 | 0 | 0 |
| Financing Cash Flow | $-65 | $-31 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 128 | -416 | -682 | 18 | -209 |
| Beginning Cash Position | 5,806 | 9,837 | 9,837 | 9,837 | 9,837 |
| End Cash Position | 4,497 | 5,806 | 6,969 | 9,199 | 11,007 |
| Net Cash Flow | $-1,309 | $-4,031 | $-2,869 | $-639 | $1,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,372 | -7,375 | -5,976 | -4,455 | -2,365 |
| Capital Expenditure | N/A | -43 | -44 | -35 | -33 |
| Free Cash Flow | -1,372 | -7,418 | -6,020 | -4,490 | -2,398 |